ResearchMoz

Term Life Assurance in the UK, Key Trends and Opportunities to 2017

Timetric
Published Date » 2014-01-09
No. Of Pages » 64
 
     
 
  Synopsis  
  
   
 
 
 The report provides market analysis, information and insights into the UK term life assurance business. 
 It provides a snapshot of market size and market segmentation. 
 It analyzes drivers and the outlook for the market. 
 It provides information on distribution channels for term life assurance products in the UK. 
 It rounds up deals, news and regulatory developments. 
 It provides a detailed analysis of the competitive landscape and key product features. 
 
 
   
  Summary  
     
 New business premiums in the term life assurance category grew by 7.7% in 2012, accompanied by an increase in mortgage-related protection sales. Term life assurance (excluding accelerated critical illness benefit) dominated the UK long-term protection...
Table of Content

1 Executive Summary

2 Introduction
2.1 What is this Report About?
2.2 Definitions
2.3 Methodology
2.4 Market Size
2.4.1 Level-term and decreasing-term assurance new business premiums
2.4.2 UK long-term protection market, new business regular premiums by category
2.4.3 Number of new term life assurance policies sold
2.5 Market Drivers
2.6 Market Outlook 
2.7 Distribution Channels

3 Competitive Landscape
3.1 Best Performers of 2012
3.2 Term Life Assurance – SWOT Analysis

4 Porter’s Five Forces Analysis
4.1 Bargaining Power of Suppliers: Low to Medium
4.2 Bargaining Power of Buyers: Medium to High
4.3 Barriers to Entry: Medium
4.4 Intensity of Rivalry: High
4.5 Threat of Substitutes: Medium

5 Deals and News
5.1 Aviva Launches Life Insurance Radio Advertising Campaign
5.2 Royal London Completes Co-Op Acquisitions
5.3 Aegon Improves Financial and Non-Medical Underwriting Limits for Protection
5.4 LV= Develops Corporate Life Product
5.5 Aviva Predicts Rise in Non-Advised Protection Sales As It Closes Direct Advice Arm
5.6 Ageas Launches Business Protection Product Suite
5.7 Ageas Adds ‘Life of Another’ Option to Product Range
5.8 Zurich and Guardian Launch Life Navigator Campaign

6 Regulation and Compliance
6.1 Regulatory Changes
6.1.1 Risk selection by gender has been outlawed
6.1.2 Retail Distribution Review
6.1.3 ‘I minus E’ taxation change
6.1.4 Consumer Insurance Act
6.1.5 Mortgage Market Review
6.1.6 Solvency II

7 Economic Backdrop
7.1 Real GDP Growth
7.2 Housing and Mortgage Market
7.1 Demographics

8 Company Profiles
8.1 Aegon UK Plc
8.1.1 Aegon UK Plc – key facts
8.1.2 Aegon UK Plc – main products 
8.1.3 Aegon UK Plc – main competitors
8.1.4 Aegon UK Plc – key employees
8.2 Aviva Plc – Company Overview 
8.2.1 Aviva Plc – key facts 
8.2.2 Aviva Plc – main products 
8.2.3 Aviva Plc – main competitors 
8.2.4 Aviva Plc – key employees 
8.3 Ageas UK Ltd – Company Overview
8.3.1 Ageas UK Ltd – key facts 
8.3.2 Ageas UK Ltd – main products 
8.3.3 Ageas UK Ltd – main competitors
8.3.4 Ageas UK Ltd – key employees
8.4 Friends Life Group Plc – Company Overview
8.4.1 Friends Life Group Plc – key facts
8.4.2 Friends Life Group Plc – main products 
8.4.3 Friends Life Group Plc – main competitors 
8.4.4 Friends Life Group Plc – key employees
8.5 Legal and General Group – Company Overview 
8.5.1 Legal and General Group – key facts
8.5.2 Legal and General Group – main products
8.5.3 Legal and General Group – main competitors
8.5.4 Legal and General Group – key employees 
8.6 Liverpool Victoria Group – Company Overview 
8.6.1 Liverpool Victoria Group – key facts 
8.6.2 Liverpool Victoria Group – main products 
8.6.3 Liverpool Victoria Group – main competitors
8.6.4 Liverpool Victoria Group – key employees 
8.7 Lloyds Banking Group – Company Overview 
8.7.1 Lloyds Banking Group – key facts 
8.7.2 Lloyds Banking Group – main products 
8.7.3 Lloyds Banking Group – main competitors 
8.7.4 Lloyds Banking Group – key employees 
8.8 Prudential Plc – Company Overview 
8.8.1 Prudential Plc – key facts 
8.8.2 Prudential Plc – main products 
8.8.3 Prudential Plc – main competitors 
8.8.4 Prudential Plc – key employees 
8.9 Royal London Group – Company Overview 
8.9.1 Royal London Group – key facts 
8.9.2 Royal London Group – main products 
8.9.3 Royal London Group – main competitors 
8.9.4 Royal London Group – key employees 
8.10 Zurich Financial Services Ltd – Company Overview 
8.10.1 Zurich Financial Services Ltd – key facts 
8.10.2 Zurich Financial Services Ltd – main products 
8.10.3 Zurich Financial Services Ltd – main competitors 
8.10.4 Zurich Financial Services Ltd – key employees 

9 Statistics 
9.1 Review Period 
9.2 Forecast Period 

10 Appendix 
10.1 Methodology 
10.2 Contact Timetric 
10.3 About Timetric 
10.4 Timetric’s Services 
10.5 Disclaimer

List of Tables


Table 1: Insurance Industry Definitions 
Table 2: Term Life Assurance – SWOT Analysis
Table 3: Recent and Upcoming Regulatory Changes
Table 4: Aegon UK Plc, Key Facts 
Table 5: Aegon UK Plc, Main Products
Table 6: Aegon UK Plc, Key Employees 
Table 7: Aviva Plc, Key Facts 
Table 8: Aviva Plc, Main Products 
Table 9: Aviva Plc, Key Employees 
Table 10: Ageas UK Ltd, Key Facts 
Table 11: Ageas UK Ltd, Main Products 
Table 12: Ageas UK Ltd, Key Employees 
Table 13: Friends Life Group Plc, Key Facts 
Table 14: Friends Life Group Plc, Main Products 
Table 15: Friends Life Group Plc, Key Employees 
Table 16: Legal and General Group, Key Facts 
Table 17: Legal and General Group, Main Products 
Table 18: Legal and General Group, Key Employees 
Table 19: Liverpool Victoria Group, Key Facts 
Table 20: Liverpool Victoria Group, Main Products 
Table 21: Liverpool Victoria Group, Key Employees 
Table 22: Lloyds Banking Group, Key Facts 
Table 23: Lloyds Banking Group, Main Products 
Table 24: Lloyds Banking Group, Key Employees 
Table 25: Prudential Plc, Key Facts 
Table 26: Prudential Plc, Main Products 
Table 27: Prudential Plc, Key Employees
Table 28: Royal London Group, Key Facts
Table 29: Royal London Group, Main Products
Table 30: Royal London Group, Key Employees
Table 31: Zurich Financial Services Ltd, Key Facts
Table 32: Zurich Financial Services Ltd, Main Products
Table 33: Zurich Financial Services Ltd, Key Employees 
Table 34: UK Term Life Assurance – New Business Premiums (GBP Thousand), 2008–2012 
Table 35: UK Term Life Assurance – New Business Premiums (GBP Thousand), 2013–2017

List of Figures


Figure 1: UK Term Life Assurance (Excluding Accelerated CI) – Total New Business Premiums (GBP Million), 2008–2012 
Figure 3: UK Long-Term Protection Market – New Business Regular Premiums by Category (GBP Million), 2008–2012 
Figure 4: Number of New Term Life Policies Sold by FSA-Regulated Life Insurers, Excluding Accelerated CI (Thousands), 2008–2012 
Figure 5: New Business Premiums for UK Term Life Assurance, Excluding Accelerated CI (GBP Million), 2013–2017 
Figure 6: Top 10 Term Life Assurance Providers Based on Total New Business Premium (Excluding Accelerated CI), 2012 (%) 
Figure 7: UK Term Life Assurance – Five Forces Analysis 
Figure 8: The UK’s Insurance Regulatory Framework 
Figure 9: Real GDP Growth (%), 2008–2017 
Figure 10: Simple Average House Prices in the UK (GBP), 1991–2012 
Figure 11: Number of First-Time Homebuyers (Thousands), 2002–2012 
Figure 12: Total Gross Mortgage Lending (GBP Million), 2002–2012 
Figure 13: Growing and Aging Population, 1995–2012 
Figure 14: UK Population Aged Over 65 (%), 1995–2017 
Figure 15: UK Overall Life Expectancy (Years), 1995–2017 
Figure 16: Improving Living Standards in the UK (GBP Thousand), 1997–2011 

Upcoming Reports:

Omega 3 And 6 Market - Global Industry size, market share, trends, analysis and forecasts 2012 - 2018
By - Transparency Market Research
Omega 3 and omega 6 are the essential fatty acids which are not synthesized by the body but are important for its metabolism. Marine oils, one of the sources of omega 3, continue to dominate the omega 3 fatty acids market. Fish oil concentrates are expected to witness highest growth in terms of volume as well as value in upcoming years.  The market for omega 3 and omega 6 is expected to witness considerable growth in the near future due to increasing market potential and growing preference from consumers. This market is expected to continue penetrating functional...
Greece: maize market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the maize market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the maize market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...
Metabolomics Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018
By - Transparency Market Research
Metabolomics is a nascent upcoming technology in the field of analytical biochemistry. It can be defined as a systematic study of unique chemical fingerprints that specific cellular processes leave behind. The metabolomics study engages study of metabolic profiles and their comparative analysis. The major hindrance profiling these metabolites is the analysis of all classes of compounds found in the organism and not a single entity like a cell, protein or DNA. Hence, to analyze such minutest details in the organism  requires robust platforms. The mass spectrometry (MS) based...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...